Anton Horrevoets Group leader
Anton Horrevoets completed his study in chemistry cum laude at Utrecht University in 1985, specializing in Biochemistry and Molecular genetics, and obtained his PhD at the Center for Biomembranes and Lipid Enzymology at Utrecht University. As Post-doctoral investigator he joined the department of Molecular Biology at Sanquin Research in Amsterdam to study the molecular biology and enzymology of thrombosis and fibrinolysis, focusing on variants of tissue-type plasminogen activator and other plasma (pro-) enzymes. During 1993-1994, with the aid of a NWO-fellowship, he visited the Departments of Biochemistry and Medicine at Queen's University, Kingston, Ontario, Canada.
In 1994 he returned to the Netherlands to enter the Molecular Cardiology Program / Atherosclerosis of the Netherlands Heart Foundation, as Career Development Awardee of the Heart Foundation and Assistant/Associate Professor in Medical Biochemistry at the department of Medical Biochemistry, Academic Medical Center, Amsterdam. Here, he investigated the endothelial cell phenotype and role in atherosclerosis using state-of-the-art molecular biological techniques. He next served as Established Investigator of the Netherlands Heart Foundation 2001-2006 with a program on endothelial cell genomics and proteomics in atherosclerosis, further supported by Genomics programs from NWO, SenterNovem and the European Union.
As of December 1, 2007 he is Professor of Biochemistry and Molecular Cell Biology at the VUmc department of Molecular Cell Biology and Immunology.